Estimates Revisions China Resources Pharmaceutical Group Limited Börse Stuttgart
Stocks
640
HK0000311099
Pharmaceuticals
|
Market Closed -
Börse Stuttgart
22:55:25 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.4660 EUR | -0.85% |
|
-1.69% | -2.51% |
| 09-01 | China Resources Pharma Unit's Bond Program Registration Accepted in China | MT |
| 08-24 | China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
China Resources Pharmaceutical Group Limited(3320)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
China Resources Pharmaceutical Group Limited(3320)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
China Resources Pharmaceutical Group Limited(3320)
EBIT
Dividend / Share (DPS)
Data source:
China Resources Pharmaceutical Group Limited(3320)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
